Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-083043
Filing Date
2023-07-21
Accepted
2023-07-21 16:07:17
Documents
3
Period of Report
2023-08-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2320771-2_def14a.htm DEF 14A 2436292
2 GRAPHIC px_aceragen03page-4c.jpg GRAPHIC 1001001
3 GRAPHIC px_aceragen04page-4c.jpg GRAPHIC 764904
  Complete submission text file 0001104659-23-083043.txt   4620751
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
Aceragen, Inc. (Filer) CIK: 0000861838 (see all company filings)

EIN.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31918 | Film No.: 231102607
SIC: 2836 Biological Products, (No Diagnostic Substances)